GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Maxigen Biotech Inc (TPE:1783) » Definitions » Total Long-Term Liabilities

Maxigen Biotech (TPE:1783) Total Long-Term Liabilities : NT$8.2 Mil (As of Mar. 2025)


View and export this data going back to 2011. Start your Free Trial

What is Maxigen Biotech Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Maxigen Biotech's Total Long-Term Liabilities for the quarter that ended in Mar. 2025 was NT$8.2 Mil.

Maxigen Biotech Total Long-Term Liabilities Historical Data

The historical data trend for Maxigen Biotech's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Maxigen Biotech Total Long-Term Liabilities Chart

Maxigen Biotech Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.66 7.40 0.57 0.51 1.49

Maxigen Biotech Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.51 0.94 1.73 1.49 8.23

Maxigen Biotech Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Maxigen Biotech Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Maxigen Biotech's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Maxigen Biotech Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Maxigen Biotech Inc (TPE:1783) » Definitions » Total Long-Term Liabilities
Comparable Companies
TPE:1752 TPE:4737 ROCO:6612 ROCO:6527 ROCO:4116 ROCO:4111 ROCO:6543 ROCO:6730 ROCO:4150 ROCO:7575 ISRG XPAR:EL BDX TSE:7741 XSWX:ALC RMD TSE:4543 OCSE:COLO B XPAR:DIM XSWX:STMN
Traded in Other Exchanges
N/A
Address
No.88, Keji 1st Road, Guishan District, Taoyuan City, TWN, 333
Website
https://www.mbi-bio.com
Maxigen Biotech Inc is engaged in collagen purification, research and development, production and sales of implantable medical device, and production, manufacturing, wholesale and retail of cosmetics. The group had two reportable segments: the biomedical products segment and consumer products segment. Biomedical products segment is engaged in the manufacturing and sales of collagen and bone materials. The consumer products segment is involved in the manufacturing and sales of beauty care products. Geographically, it operates in Taiwan, America, Europe, Asia, and other countries, with the majority of the revenue deriving from Taiwan.

Maxigen Biotech Headlines

No Headlines